As a result of the disruption from the global crisis caused by the coronavirus, or COVID-19, the company is changing its date for publication of...
Mauna Kea Technologies provides business update
read more
Search Results
Mauna Kea Technologies Receives FDA Clearance and CE Marking For Its Next-Generation Cellvizio® Platform
The new Cellvizio® platform includes significant improvements and will enable major innovations Mauna Kea Technologies announced...
Mauna Kea Technologies reports fourth quarter and full year 2019 sales
Full Year 2019 total sales up 10% Sales to clinical customers up 27%, driven by 89% growth in consumables sales related to pay-per-use...
Mauna Kea Technologies Receives FDA 510(k) Clearance of Cellvizio® with a Fluorescent Dye, Fluorescein, as Drug Device Combination
The Cellvizio® 100 series system with all its different Confocal Miniprobes™ is now cleared for use with the fluorescein dye to image...
Positive Results on Needle-Based Endomicroscopy for the Clinical Management of Pancreatic Cystic Lesions
Clinical trial published in peer-reviewed journal demonstrates diagnostic yield from Cellvizio® significantly exceeds standard of care (84.1% vs...
Mauna Kea Technologies Announces Strategic Equity Investment of €7.5 Million by Johnson & Johnson Innovation
Mauna Kea Technologies today announced a strategic equity investment of 7.5 million euro by Johnson & Johnson Innovation – JJDC, Inc....
Mauna Kea Technologies Participates in Dutch Molecular Imaging Consortium that was Awarded €5.4 Million
MEDPHOT consortium aims to develop light-based molecular imaging solution for pulmonary diseases Mauna Kea Technologies today announced...
Third Quarter Sales and First Nine Months of 2019 Sales
READ THE COMPLETE PRESS RELEASE
Positive Results on Needle-Based Endomicroscopy for Differentiating and Managing Pancreatic Cystic Lesions
Three recent clinical publications demonstrate that Cellvizio® AQ-Flex™ 19 Confocal Miniprobe significantly improves...
First Half 2019 Financial Results
READ THE COMPLETE PRESS RELEASE
Mauna Kea Technologies to Publish 2019 First Half Results on September 23, 2019
READ THE COMPLETE PRESS RELEASE
Mauna Kea Technologies Reports Second Quarter and First Half 2019 Sales
Q2 Sales up 33% year-over-year & First Half 2019 sales up 45% year-over-year. Consumables sales represent the largest driver of growth in both...